
|Articles|November 17, 2003
First drug approved for severe Alzheimer's
Clinicians will soon be able to treat patients with advanced Alzheimer?s disease (AD) using the first drug approved for use in the later stages of this progressive condition. The FDA recently approved memantine (Namenda, Forest Laboratories) for the treatment of moderate to severe AD. The drug will be available in pharmacies January.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Social and Economic Factors Significantly Influence Supply of OTC Antibiotics
2
What TrumpRx Means for Independent Pharmacies and Their Patients
3
Oral Semaglutide Show Promise as New Benchmark for Diabetes Care, Cardiovascular Protection
4
Transforming Pharmacy Profits Through Medicare Advantage OTC Programs
5




























































































































